Adjunctive therapies in chronic lung disease: Examining the evidence

Weis, 1996, Oxygen therapy, 538 Tin, 2003, The medical use of oxygen: a century of research in animals and humans, Neo Reviews, 4, e340 Campbell, 1951, Intensive oxygen therapy as a possible cause of retrolental fibroplasia: a clinical approach, Med J Aust, ii, 48, 10.5694/j.1326-5377.1951.tb109040.x Askie, 2000, Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants, Cochrane Database Syst Rev, CD001077 Northway, 1967, Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia, N Engl J Med, 267, 357, 10.1056/NEJM196702162760701 Saugstad, 2003, Bronchopulmonary dysplasia – oxidative stress and oxidants, Semin Neonatol, 8, 39, 10.1016/S1084-2756(02)00194-X 2000, Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes, Pediatrics, 105, 295, 10.1542/peds.105.2.295 Askie, 2003, Oxygen-saturation targets and outcomes in extremely preterm infants, N Engl J Med, 349, 959, 10.1056/NEJMoa023080 Flynn, 1992, A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity, N Engl J Med, 326, 1050, 10.1056/NEJM199204163261603 Tin, 2001, Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation, Arch Dis Child, 84, F106, 10.1136/fn.84.2.F106 Chow, 2003, Can changes in clinical practice decrease the incidence of severe retinopathy in very low birth weight infants?, Pediatrics, 111, 339, 10.1542/peds.111.2.339 Anderson, 2004, Retinopathy of prematurity and pulse oximetry: a national survey of recent practices, J Perinatol, 24, 164, 10.1038/sj.jp.7211067 Sun, 2002, Relation of target SpO2 levels and clinical outcome in ELBW infants on supplemental oxygen, Pediatr Res, 51, A350 Bradley, 2004, Early oxygen exposure and outcome at 10 years in babies of less than 28 weeks gestation, Pediatr Res, 55, A373 Poets, 2003, Retinopathy of prematurity: a comparison between two centers aiming for different pulse oximetry saturation levels, Biol Neonate, 84, A267 Vijayakumar, 1997, Pulse oximetry in infants <1500gm birth weight on supplemental oxygen: a national survey, J Perinatol, 17, 341 Tin, 2002, Giving small babies oxygen: 50 years of uncertainty, Semin Neonatol, 7, 361, 10.1053/siny.2002.0130 Silverman, 2004, A cautionary tale about supplemental oxygen: the albatross of neonatal medicine, Pediatrics, 113, 394, 10.1542/peds.113.2.394 Millar, 2004, Controversies surrounding xanthine therapy, Semin Neonatol, 9, 239, 10.1016/j.siny.2003.11.008 Weinberg, 2002 Davi, 1978, Physiologic changes induced by theophylline in the treatment of apnea in preterm infants, J Pediatr, 92, 91, 10.1016/S0022-3476(78)80084-5 Von Poblotzki, 2003, Effects of theophylline on the pattern of spontaneous breathing in preterm infants less than 1000g of birth weight, Early Hum Dev, 72, 47, 10.1016/S0378-3782(03)00010-0 Rigatto, 1981, The effect of 2% CO2, 100% O2, theophylline and 15% O2 on ‘inspiratory drive’ and ‘effective’ timing in preterm infants, Early Hum Dev, 5, 63, 10.1016/0378-3782(81)90071-2 Henderson-Smart, 1999, Prophylactic methylxanthine for prevention of apnea in preterm infants, Cochrane Database Syst Rev, CD000432 Henderson-Smart, 2000, Doxapram versus methylxanthine for apnea in preterm infants, Cochrane Database Syst Rev, CD000075 Henderson-Smart, 2001, Methylxanthine treatment for apnea in preterm infants, Cochrane Database Syst Rev, CD000140 Henderson-Smart, 2003, Prophylactic methylxanthines for extubation in preterm infants, Cochrane Database Syst Rev, CD000139 2003 Schmidt, 2006, Caffeine therapy for apnoea of prematurity, N Engl J Med, 354, 2112, 10.1056/NEJMoa054065 Schmidt, 2007, The International Caffeine for Apnea of Prematurity (CAP) trial: preliminary analysis of outcomes at a corrected age of 18–21 months, E-PAS, 61, 5130.1 Halliday, 2003, Early (<96hours) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev, CD001146 Halliday, 2003, Moderately early (7–14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev, CD001144 Halliday, 2003, Delayed (>3 weeks) postnatal corticosteroids for preventing chronic lung disease in preterm infants, Cochrane Database Syst Rev, CD001145 Shah, 2003, Inhaled versus systemic corticosteroids for preventing chronic lung disease in ventilated very low birth weight preterm neonates, Cochrane Database Syst Rev, CD002058 Shah, 2003, Inhaled versus systemic corticosteroids for the treatment of chronic lung disease in ventilated very low birth weight preterm infants, Cochrane Database Syst Rev, CD002057 2002, Postnatal corticosteroids to treat or prevent chronic lung disease in preterm infants, Pediatrics, 109, 330, 10.1542/peds.109.2.330 Doyle, 2006, Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomised, controlled trial, Pediatrics, 117, 75, 10.1542/peds.2004-2843 Doyle, 2007, Outcome at 2 years of age of infants from the DART study: a multicenter, international, randomised controlled trial of low-dose dexamethasone, Pediatrics, 119, 716, 10.1542/peds.2006-2806 Doyle, 2005, Impact of postnatal systemic corticosteroids on mortality and cerebral palsy in preterm infants: effect modification by risk for chronic lung disease, Pediatrics, 115, 655, 10.1542/peds.2004-1238 Brion, 2001, Diuretics for respiratory distress syndrome in preterm infants, Cochrane Database Syst Rev, 10.1002/14651858.CD001454 Brion, 2000, Intravenous or enteral loop diuretics for preterm infants with (or developing) chronic lung disease, Cochrane Database Syst Rev, CD001453 Brion, 2006, Aerosolized diuretics for preterm infants with (or developing) chronic lung disease, Cochrane Database Syst Rev, 10.1002/14651858.CD001694.pub2 Brion, 2002, Diuretics acting on the distal renal tubule for preterm infants with (or developing) chronic lung disease, Cochrane Database Syst Rev, CD001817 Kinsella, 2000, Clinical approach to inhaled nitric oxide therapy in the newborn with hypoxemia, J Pediatr, 136, 717, 10.1067/mpd.2000.107189 Kang, 2002, Inhaled nitric oxide attenuates acute lung injury via inhibition of nuclear factor-kappa B and inflammation, J Appl Physiol, 92, 795, 10.1152/japplphysiol.00202.2001 Ballard, 2006, Surfactant composition and function in a primate model of infant chronic lung disease: effect of inhaled nitric oxide, Pediatr Res, 59, 157, 10.1203/01.pdr.0000190664.69081.f1 McCurnin, 2005, Inhaled NO improves early pulmonary function and modifies lung growth and elastin deposition in a baboon model of neonatal chronic lung disease, Am J Physiol Lung Cell Mol Physiol, 288, L450, 10.1152/ajplung.00347.2004 Roberts, 1992, Inhaled nitric oxide in persistent pulmonary hypertension of the newborn, Lancet, 340, 818, 10.1016/0140-6736(92)92686-A Kinsella, 1992, Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newborn, Lancet, 340, 819, 10.1016/0140-6736(92)92687-B Finer NN, Barrington KJ. Nitric oxide for respiratory failure in infants born at or near term. Cochrane Database Syst Rev 2006;(4):CD000399. Barrington, 2006, Inhaled nitric oxide for respiratory failure in preterm infants, Cochrane Database Syst Rev, CD000509 Banks, 1999, Changes in oxygenation with inhaled nitric oxide in severe bronchopulmonary dysplasia, Pediatrics, 103, 610, 10.1542/peds.103.3.610 Clark, 2002, Safety and efficacy of nitric oxide in chronic lung disease, Arch Dis Child, 86, F41, 10.1136/fn.86.1.F41 Kinsella, 1999, Inhaled nitric oxide in premature neonates with severe hypoxemic respiratory failure: a randomised controlled trial, Lancet, 354, 1061, 10.1016/S0140-6736(99)03558-8 Field, 2005, Neonatal ventilation with inhaled nitric oxide versus ventilatory support without inhaled nitric oxide for preterm infants with severe respiratory failure: the INNOVO multicentre randomised controlled trial (ISRCTN 17821339), Pediatrics, 115, 926, 10.1542/peds.2004-1209 Van Meurs, 2005, Inhaled nitric oxide for premature infants with severe respiratory failure, N Engl J Med, 353, 13, 10.1056/NEJMoa043927 Schreiber, 2003, Inhaled nitric oxide in premature infants with the respiratory distress syndrome, N Engl J Med, 349, 2099, 10.1056/NEJMoa031154 Kinsella, 2006, Early inhaled nitric oxide therapy in premature newborns with respiratory failure, N Engl J Med, 355, 354, 10.1056/NEJMoa060442 Ballard, 2006, Inhaled nitric oxide in preterm infants undergoing mechanical ventilation, N Engl J Med, 355, 343, 10.1056/NEJMoa061088 Stark, 2006, Inhaled NO for preterm infants – getting to yes?, N Engl J Med, 355, 404, 10.1056/NEJMe068129 Bancalari, 2001, Changes in the pathogenesis and prevention of chronic lung disease of prematurity, Am J Perinatol, 18, 1, 10.1055/s-2001-12940 Fowlie, 2002, Prophylactic intravenous indomethacin for preventing mortality and morbidity in preterm infants, Cochrane Database Syst Rev, CD000174 Schmidt, 2001, Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants, N Engl J Med, 344, 1966, 10.1056/NEJM200106283442602 Shah, 2006, Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants, Cochrane Database Syst Rev, CD004213 Denjean, 1998, Inhaled salbutamol and beclomethasone for preventing broncho-pulmonary dysplasia: a randomised double-blind study, Eur J Pediatr, 157, 926, 10.1007/s004310050969 Ng, 2001, Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants, Cochrane Database Syst Rev, CD003214 Wilkie, 1987, Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease, J Pediatr, 111, 278, 10.1016/S0022-3476(87)80087-2 Brundage, 1990, Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia, Am Rev Respir Dis, 142, 1137, 10.1164/ajrccm/142.5.1137 Yuksel, 1991, Ipratropium bromide for symptomatic preterm infants, Eur J Pediatr, 150, 854, 10.1007/BF01955008 Watterburg, 1993, Failure of cromolyn sodium to reduce the incidence of bronchopulmonary dysplasia, Pediatrics, 91, 803, 10.1542/peds.91.4.803 Viscardi, 1997, Cromolyn sodium prophylaxis inhibits pulmonary proinflammatory cytokines in infants at high risk for bronchopulmonary dysplasia, Am J Respir Crit Care Med, 156, 1523, 10.1164/ajrccm.156.5.9611088 Tyson, 1999, Vitamin A supplementation for extremely-low-birth infants, N Engl J Med, 340, 1962, 10.1056/NEJM199906243402505 Darlow, 2002, Vitamin A supplementation for preventing morbidity and mortality in very low birth weight infants, Cochrane Database Syst Rev, CD00501 Wardle, 2001, Randomised controlled trial of vitamin A supplementation in preterm infants to prevent chronic lung disease, Arch Dis Child, 84, F9, 10.1136/fn.84.1.F9 Brion, 2003, Vitamin E supplementation for prevention of morbidity and mortality in preterm infants, Cochrane Database Syst Rev, CD003665 Rosenfeld, 1984, Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome, J Pediatr, 105, 781, 10.1016/S0022-3476(84)80307-8 Davis, 1997, Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome, Pediatrics, 100, 24, 10.1542/peds.100.1.24